SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 24th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 24th, 2023 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of November 3, 2022 between Propanc Biopharma, Inc. a Delaware corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (“Investor”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 24th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 24th, 2023 Company Industry JurisdictionThis Common Stock Purchase Agreement (the “Agreement”) is entered into as of November 3, 2022, by and between PROPANC BIOPHARMA INC., a Delaware corporation (the “Company”), and COVENTRY ENTERPRISES, LLC, a Delaware limited liability company (the “Investor”). The Company and Investor may be referred to herein as each a ‘‘Party” and collectively, the “Parties”.